首页> 外文期刊>Critical Reviews in Food Science and Nutrition >Metabolic engineering pathways for rare sugars biosynthesis, physiological functionalities, and applications-a review
【24h】

Metabolic engineering pathways for rare sugars biosynthesis, physiological functionalities, and applications-a review

机译:用于稀糖生物合成,生理学功能和应用的代谢工程途径 - 审查

获取原文
获取原文并翻译 | 示例
           

摘要

Biomolecules like rare sugars and their derivatives are referred to as monosaccharides particularly uncommon in nature. Remarkably, many of them have various known physiological functions and biotechnological applications in cosmetics, nutrition, and pharmaceutical industries. Also, they can be exploited as starting materials for synthesizing fascinating natural bioproducts with significant biological activities. Regrettably, most of the rare sugars are quite expensive, and their synthetic chemical routes are both limited and economically unfeasible due to expensive raw materials. On the other hand, their production by enzymatic means often suffers from low space-time yields and high catalyst costs due to hasty enzyme denaturation/degradation. In this context, biosynthesis of rare sugars with industrial importance is receiving renowned scientific attention, across the globe. Moreover, the utilization of renewable resources as energy sources via microbial fermentation or microbial metabolic engineering has appeared a new tool. This article presents a comprehensive review of physiological functions and biotechnological applications of rare ketohexoses and aldohexoses, including D-psicose, D-tagatose, L-tagatose, D-sorbose, L-fructose, D-allose, L-glucose, D-gulose, L-talose, L-galactose, and L-fucose. Novel in-vivo recombination pathways based on aldolase and phosphatase for the biosynthesis of rare sugars, particularly D-psicose and D-sorbose using robust microbial strains are also deliberated.
机译:生物分子如稀有糖及其衍生物被称为单糖,特别是本质上特别罕见。值得注意的是,其中许多人在化妆品,营养和制药行业中具有各种已知的生理功能和生物技术应用。此外,它们可以被利用为合成具有重要生物活性的迷人天然生物产物的起始材料。令人遗憾的是,大多数稀有糖都是非常昂贵的,并且由于昂贵的原料,它们的合成化学途径都有限,经济地不可行。另一方面,由于仓促酶变性/降解,它们通过酶促的生产通常存在低空时间产率和高催化剂成本。在这种情况下,具有工业重要性的稀糖的生物合成在全球接受着名的科学关注。此外,通过微生物发酵或微生物代谢工程利用可再生资源作为能源出现了一种新工具。本文介绍了罕见的克里霍塞斯和醛己化的生理功能和生物技术应用的全面审查,包括D-Psicose,D-Tagatose,L-Tagatose,D-山梨糖,L-果糖,D- allose,L-葡萄糖,D-甘油,L-缩略图,L-半乳糖和L-岩藻糖。基于醛糖酶和磷酸酶的新型体内重组途径,用于稀有糖的生物合成,特别是使用鲁棒微生物菌株的D-雌蕊和D-山梨糖。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号